Dr. Narendra Pandey, founder of Asian Institute of Medical Sciences (AIMS), is actively pursuing an AIMS hospital buyback. He aims to reacquire the 49% stake. This stake is currently held by private equity investors in the Faridabad-based facility. This move highlights a growing trend among founders. They want to consolidate ownership in successful healthcare ventures. Dr. Pandey founded AIMS fifteen years ago.
Financing the AIMS Hospital Buyback
Dr. Pandey is engaged in discussions with various credit arms, including Avendus, KKR, and Kotak. He seeks to secure approximately ₹500 crore. This substantial capital will finance the proposed buyout. British International Investment (BII) and Orbimed own these stakes. These private equity firms had invested in Blue Sapphire Healthcare, AIMS’s holding company. Therefore, securing this funding is a crucial step. The hospital boasts 450 beds. Its estimated value lies between ₹1,000 crore and ₹1,200 crore.
Healthcare Sector Dynamics and Valuations
The healthcare delivery sector in India has experienced considerable deal activity; moreover, valuations have become notably aggressive. Individual hospitals and smaller chains frequently command valuations of 25-30 times their earnings. Against this backdrop, Dr. Pandey’s desire to retain control of his company reflects a strategic decision. Consequently, this indicates confidence in AIMS’s long-term growth prospects. Earlier this year, Manipal Hospitals acquired Sahyadri Hospitals in Maharashtra for ₹6,400 crore. Furthermore, KKR recently purchased Baby Memorial Hospital for ₹2,000 crore. These deals underscore the robust investment appetite in the sector. For those looking to understand the financial aspects of healthcare management, a course in Critical Care might offer insights into resource allocation and investment strategies within specialized medical fields.
Previous Attempts and Market Perception
Last year, BII and Orbimed had attempted a secondary sale of their holdings in AIMS to other private equity firms. However, this initiative did not gain traction. Potential buyers perhaps perceived the valuation demands as too high at that time. Therefore, Dr. Pandey’s current buyback effort provides a new avenue for these investors to exit. Alvarez and Marsal reportedly advise Dr. Pandey on his fundraising efforts.
Frequently Asked Questions
Q1: Who is looking to buy back stakes in AIMS hospital?
Dr. Narendra Pandey, the founder of Asian Institute of Medical Sciences (AIMS), is seeking to buy back the 49% stake held by private equity investors.
Q2: What is the estimated valuation of AIMS hospital?
AIMS hospital is estimated to be valued between ₹1,000 crore and ₹1,200 crore.
Q3: Which private equity firms are involved in the stake sale?
British Investment (BII) and Orbimed are the private equity investors whose stakes Dr. Pandey intends to buy back.
References
- AIMS hospital founder looks to buy back PE investors’ 49% stake – ETHealthworld
- Healthcare Investment in India: Trends, Insights & Strategy – Market Xcel
- AIMS hospital founder looks to buy back PE investors’ 49% stake – The Economic Times
- India’s Healthcare Industry Comes of Age | Bain & Company
- Asian Institute of Medical Sciences raises funding from CDC – VCCircle
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.